Blockchain Pharmaceuticals Creates First Decentralized Pharmaceutical Company
NEW YORK, NY / ACCESSWIRE / April 21, 2021 / Blockchain Pharmaceuticals today completed development on its first layer of...
Month: April 2021
REMINDER FROM JAGUAR HEALTH: Innovators with Jane King Webcast Interview to Take Place Friday, April 23, 2021 at 8:30 AM Eastern to Provide a Business Overview of Napo EU S.p.A., Jaguar’s New Italian Subsidiary
Registration link for webcast interview appears below SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Jaguar Health, Inc....
AngioSoma, Inc. Is Pleased To Welcome Steven F. Penderghast To Its Board Of Directors
Penderghast’s Experience Medical Sciences Will Play a Key Role in the Growth of AngioSoma RICHLAND, WA / ACCESSWIRE / April...
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations
JACKSON CENTER, PA / ACCESSWIRE / April 21, 2021 / Halberd Corporation's (OTC PINK:HALB) two patent-pending monoclonal antibodies have demonstrated...
Kadmon Announces Publication of Phase 2a Clinical Trial Results of Belumosudil for cGVHD in the Journal of Clinical Oncology
NEW YORK, NY / ACCESSWIRE / April 21, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced the publication of results from...
Novamind Collaborates with Center for Change
Novamind working with Center for Change to treat patients, conduct research TORONTO, ON / ACCESSWIRE / April 21, 2021 /...
9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit
RALEIGH, NC / ACCESSWIRE / April 21, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare...
Reducing a Variety of Strains with Eye Yoga
Quebec’s Karma Shala Online Has The AnswersMONT TREMBLANT, Quebec, April 21, 2021 (GLOBE NEWSWIRE) -- Technology has been a great...
Chiesi Group receives European Marketing Authorization for Trimbow® inhalation powder (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium) delivered through NEXThaler, an extrafine formulation fixed triple combination therapy for the treatment of moderate to severe COPD
Chronic obstructive pulmonary disease (COPD) patients for whom a dry powder inhaler device is preferred, can now benefit from an...
CohBar Completes Last Subject Visit in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
MENLO PARK, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Medicenna Therapeutics Announces the Appointment of Industry Veteran, Kevin Moulder, PhD, as Chief Scientific Officer
TORONTO and HOUSTON, April 21, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA),...
Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom
Recommends Special Arrangement Designation Which Increases Reimbursement OptionsNEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH),...
Ortho Clinical Diagnostics to Report First Quarter 2021 Results on May 5, 2021
RARITAN, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in...
REPEAT: Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
Vericel to Report First-Quarter 2021 Financial Results on May 5, 2021
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Allogene Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to ALLO-715, an AlloCAR T™ Cell Therapy in Development for Relapsed/Refractory Multiple Myeloma
RMAT Designation Follows Proof-of-Concept Data from ALLO-715 UNIVERSAL Trial in Heavily Pretreated, Refractory Multiple Myeloma PatientsUNIVERSAL Trial Demonstrated for the...
WW Schedules First Quarter 2021 Earnings Conference Call
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) will release its results for the first...
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
- 9 Month Interim Analysis of Open-label Study to be Presented at a Major Scientific Conference in July 2021 as an...
Clubhouse Media to Leverage Its 280M Global Social Media Reach in Blossoming NFT Market with New Crypto Content Strategy
New BlockhouseCH House will seek to Coordinate Top Creators and Experts to Drive Value in Emerging Tokenized Digital Content MarketplaceLOS...